TipRanks
Go Ultimate55% OFF

Genscript Biotech (GNNSF) Stock Forecast & Price Target

22 Followers
See the Price Targets and Ratings of:

GNNSF Analyst Ratings

Strong Buy
7Ratings
7Buy0Hold0Sell
Based on 7 analysts giving stock ratings to Genscript Biotech in the past 3 months

GNNSF Stock 12 Month Forecast

$4.76▲(5.77% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Genscript Biotech in the last 3 months. The average price target is $4.76 with a high forecast of $7.09 and a low forecast of $3.82. The average price target represents a 5.77% change from the last price of $4.50.
Highest Price Target$7.09Average Price Target$4.76Lowest Price Target$3.82

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GNNSF
Price TargetFollowArticle
J.P. Morgan$5.23buy16.13%UpsideReiterated09/17/26
CSC Financial Analyst forecast on GNNSFUnknown AnalystNot RankedCSC Financial$6.15→$7.09buy57.46%UpsideReiterated09/17/26
Jefferies$3.82buy-15.02%DownsideReiterated08/20/26
Guotai Haitong Analyst forecast on GNNSFUnknown AnalystNot RankedGuotai Haitong$4.40buy-2.25%DownsideReiterated08/20/26
BOCOM International Holdings Company Analyst forecast on GNNSFUnknown AnalystNot RankedBOCOM International Holdings Company$4.10buy-8.79%DownsideReiterated08/19/26
Huatai Securities Analyst forecast on GNNSFUnknown AnalystNot RankedHuatai Securities$4.60buy2.20%UpsideReiterated08/18/26
CICC Analyst forecast on GNNSFUnknown AnalystNot RankedCICC$4.08buy-9.36%DownsideReiterated08/17/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
RZLTRezolute
PTGXProtagonist Therapeutics
VRDNViridian Therapeutics
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Genscript Biotech

3 Months
Yang Huang
Yang HuangJ.P. Morgan
Success Rate4/4 ratings generated profit
100%
Average Return
+35.08%

Copying Yang Huang's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +35.08% per trade.

1 Year
Cui Cui
Cui CuiJefferies
Success Rate2/2 ratings generated profit
100%
Average Return
+116.70%

Copying Cui Cui's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +116.70% per trade.

2 Years
Cui Cui
Cui CuiJefferies
Success Rate2/2 ratings generated profit
100%
Average Return
+116.70%

Copying Cui Cui's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +116.70% per trade.

GNNSF Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for GNNSF
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy11122
Buy10677
Hold00000
Sell00000
Strong Sell00000
total21799

In the current month, GNNSF has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GNNSF average Analyst price target in the past 3 months is 4.76.

GNNSF Financial Forecast

$-2$-1$0$1$2Q2 2025Q2 2026Q4 2026
High$0.01
Consensus$0.01
Low$0.01

GNNSF Earnings Forecast

Next quarter’s earnings estimate for GNNSF is $0.01 with a range of $0.01 to $0.01. The previous quarter’s EPS was -$0.06. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$32.9M$153.5M$274.1M$394.7M$515.3MQ2 2025Q2 2026Q4 2026
High$496M
Consensus$496M
Low$496M

GNNSF Sales Forecast

Next quarter’s sales forecast for GNNSF is $495.80M with a range of $495.80M to $495.80M. The previous quarter’s sales results were $403.17M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

GNNSF Stock Forecast FAQ

What is GNNSF’s average 12-month price target, according to analysts?
Based on analyst ratings, Genscript Biotech’s 12-month average price target is $4.76.
What is GNNSF’s upside potential, based on the analysts’ average price target?
Genscript Biotech has 5.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GNNSF a Buy, Sell or Hold?
Genscript Biotech has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Genscript Biotech’s price target?
The average price target for Genscript Biotech is $4.76. This is based on 7 12-month price targets, issued in the past 3 months. The highest analyst price target is $7.09, the lowest forecast is $3.82. The average price target represents a 5.77% increase from the current price of $4.5.
What do analysts say about Genscript Biotech?
Genscript Biotech’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Street analysts.
How can I buy shares of GNNSF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.